Glaxo: A bigger story than a Bonus.
As the company is all set to announce its full year result for the year ended December 31, 2013 where rumors mill reefs a story of bonus being announced by the company. Is that it for Glaxo or is there something else to be uncovered to boost the company. Recently, across the globe we have seen a phenomena of buy backs in pharmaceuticals with India being most current where British Pharma major GSK announced an open to offer to buy 24.33 percent stake in its Indian arm GlaxoSmithKline Pharmaceuticals, triggering a nearly 20% surge in share prices of the local unit on BSE. If the same case happens in Pakistan equity markets where parent company offers to buy the local unit, stock price for Glaxo might surge from 40 – 50%. – Sources.
Add comment